Exploring the Multifactorial Landscape of Penile Cancer: A Comprehensive Analysis of Risk Factors.
circumcision
early detection
epidemiology
human papillomavirus
penile cancer
risk factors
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
16 Aug 2024
16 Aug 2024
Historique:
received:
31
07
2024
revised:
10
08
2024
accepted:
14
08
2024
medline:
31
8
2024
pubmed:
31
8
2024
entrez:
29
8
2024
Statut:
epublish
Résumé
Penile cancer, while rare, is a critical public health issue due to its profound impact on patients and the complexities of its management. The disease's multifactorial etiology includes risk factors such as HPV infection, poor hygiene, smoking, genetic predispositions, and socioeconomic determinants. This article provides a comprehensive review and analysis of these diverse risk factors, aiming to enhance understanding of the disease's underlying causes. By elucidating these factors, the article seeks to inform and improve prevention strategies, early detection methods, and therapeutic interventions. A nuanced grasp of the multifactorial nature of penile cancer can enable healthcare professionals to develop more effective approaches to reducing incidence rates and improving patient outcomes.
Identifiants
pubmed: 39202278
pii: diagnostics14161790
doi: 10.3390/diagnostics14161790
pmc: PMC11353487
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Cancers (Basel). 2022 Jul 20;14(14):
pubmed: 35884575
Transl Androl Urol. 2017 Oct;6(5):874-878
pubmed: 29184785
Urol Oncol. 2018 Jan;36(1):14.e17-14.e24
pubmed: 29031418
Clin Epigenetics. 2022 Oct 25;14(1):133
pubmed: 36284309
Future Sci OA. 2021 Feb 04;7(4):FSO674
pubmed: 33815820
Infect Agent Cancer. 2020 May 01;15:26
pubmed: 32377231
Sex Transm Infect. 2001 Jun;77(3):226
pubmed: 11402247
BJU Int. 2017 Feb;119(2):254-260
pubmed: 27373878
Cancer. 2008 Nov 15;113(10 Suppl):3036-46
pubmed: 18980286
Cureus. 2022 Oct 8;14(10):e30068
pubmed: 36238422
Oncol Rev. 2012 Oct 05;6(2):e17
pubmed: 25992215
Front Immunol. 2018 Jun 11;9:1253
pubmed: 29942303
Front Oncol. 2020 Dec 14;10:596261
pubmed: 33381457
Cent European J Urol. 2014;67(2):126-32
pubmed: 25140224
Healthcare (Basel). 2023 Dec 04;11(23):
pubmed: 38063659
Microorganisms. 2021 Oct 03;9(10):
pubmed: 34683414
J Urol. 2015 Apr;193(4):1245-51
pubmed: 25463996
J Urol. 2024 Mar;211(3):354-363
pubmed: 38079459
Hum Genomics. 2023 Dec 19;17(1):116
pubmed: 38111044
Int J Cancer. 2005 Sep 10;116(4):606-16
pubmed: 15825185
Sex Transm Dis. 2007 Jul;34(7):479-84
pubmed: 17413536
Nat Rev Dis Primers. 2021 Feb 11;7(1):11
pubmed: 33574340
Cancer Causes Control. 2009 May;20(4):449-57
pubmed: 19082746
Lancet Oncol. 2019 Jan;20(1):145-158
pubmed: 30573285
Int Braz J Urol. 2008 Sep-Oct;34(5):587-91; discussion 591-3
pubmed: 18986562
BMC Urol. 2016 Jul 13;16(1):42
pubmed: 27411982
Front Oncol. 2024 May 22;14:1375882
pubmed: 38841163
Nat Rev Urol. 2022 Apr;19(4):231-239
pubmed: 34937881
Medicina (Kaunas). 2024 Feb 28;60(3):
pubmed: 38541140
Singapore Med J. 2015 Nov;56(11):637-40
pubmed: 26668410
Curr Opin Urol. 2019 Jul;29(4):364-370
pubmed: 31045928
Int J Colorectal Dis. 2016 May;31(5):997-1004
pubmed: 26979979
Transl Androl Urol. 2017 Oct;6(5):791-802
pubmed: 29184775
World J Urol. 2009 Apr;27(2):141-50
pubmed: 18607597
Eur Urol Oncol. 2024 Aug;7(4):778-785
pubmed: 37949729
Can J Urol. 2011 Feb;18(1):5524-8
pubmed: 21333043
Cancers (Basel). 2023 May 11;15(10):
pubmed: 37345055
Prev Med. 2022 Mar;156:106960
pubmed: 35065979
Transl Androl Urol. 2017 Oct;6(5):785-790
pubmed: 29184774
Cancers (Basel). 2023 Jan 19;15(3):
pubmed: 36765574
Int Braz J Urol. 2011 Mar-Apr;37(2):231-40; discussion 240-3
pubmed: 21557840
Sex Med. 2019 Dec;7(4):403-408
pubmed: 31530474
Curr Probl Cancer. 2015 May-Jun;39(3):126-36
pubmed: 26076979
Cancer Causes Control. 2001 Apr;12(3):267-77
pubmed: 11405332
Can J Urol. 2021 Jun;28(3):10713-10718
pubmed: 34129468
Int J Urol. 2013 Aug;20(8):769-75
pubmed: 23573952
Einstein (Sao Paulo). 2020 Nov 06;18:eAO5577
pubmed: 33174969
Eur Urol. 2024 Aug;86(2):114-127
pubmed: 38670879
Urology. 2010 Aug;76(2 Suppl 1):S2-6
pubmed: 20691882
Adv Urol. 2011;2011:812368
pubmed: 21687572
Oncogene. 1999 Dec 20;18(55):7873-82
pubmed: 10630640
Int J Urol. 2024 Mar;31(3):274-279
pubmed: 38014575
J Clin Oncol. 2007 Oct 10;25(29):4550-6
pubmed: 17925550
Can Urol Assoc J. 2019 Feb;13(2):32-37
pubmed: 30138094
Dtsch Arztebl Int. 2018 Sep 28;115(39):646-652
pubmed: 30375327
West Indian Med J. 2014 Jul 3;63(6):559-60
pubmed: 26225809
Cancer. 2013 Jun 15;119(12):2291-9
pubmed: 23580435
Dtsch Arztebl Int. 2016 May 13;113(19):337-43
pubmed: 27232363
BJU Int. 2000 Feb;85(3):299-301
pubmed: 10671885
Urology. 2020 Jan;135:11-19
pubmed: 31605681
Urol Oncol. 2019 Jul;37(7):403-408
pubmed: 31053523
Int J Mol Sci. 2013 Sep 26;14(10):19494-505
pubmed: 24077122
PLoS One. 2018 Oct 12;13(10):e0205350
pubmed: 30312320
Pathogens. 2020 Jun 18;9(6):
pubmed: 32570816
Eur Urol. 2023 Jun;83(6):548-560
pubmed: 36906413
Can Urol Assoc J. 2019 Feb;13(2 Suppl 1):S2-S8
pubmed: 31237837
Br J Dermatol. 2001 Jul;145(1):85-9
pubmed: 11453912
J Oncol. 2012;2012:608406
pubmed: 22927846
Viruses. 2017 Dec 19;9(12):
pubmed: 29257060
Cells. 2021 Apr 06;10(4):
pubmed: 33917394
J Urol. 2014 Jul;192(1):120-5
pubmed: 24373799
Ther Adv Med Oncol. 2022 Sep 24;14:17588359221127254
pubmed: 36172172
Int Braz J Urol. 2021 Nov-Dec;47(6):1259-1263
pubmed: 34115455
Cancer Causes Control. 2011 Aug;22(8):1097-110
pubmed: 21695385
Cell. 1990 Dec 21;63(6):1129-36
pubmed: 2175676
Curr Opin Urol. 2019 Mar;29(2):145-149
pubmed: 30562185
J Basic Clin Physiol Pharmacol. 2023 Mar 20;34(3):383-389
pubmed: 36933235
Cancers (Basel). 2024 Mar 28;16(7):
pubmed: 38610987
Int J Surg Pathol. 2001 Apr;9(2):111-20
pubmed: 11484498
Skin Health Dis. 2023 Aug 12;3(6):e274
pubmed: 38047263
Cureus. 2023 Jun 24;15(6):e40909
pubmed: 37496530
Cancers (Basel). 2023 Jul 21;15(14):
pubmed: 37509374
Biomed Rep. 2021 Jul;15(1):60
pubmed: 34094536
Int J Environ Res Public Health. 2021 Aug 11;18(16):
pubmed: 34444249
J Appl Genet. 2017 Aug;58(3):321-330
pubmed: 27943120
Br J Cancer. 2005 Apr 25;92(8):1388-92
pubmed: 15812547
Transl Oncol. 2022 Jan;15(1):101267
pubmed: 34773828
Int J Mol Sci. 2023 Nov 27;24(23):
pubmed: 38069131
Oncology (Williston Park). 2016 Mar;30(3):245-9
pubmed: 26984219
Ther Adv Urol. 2013 Jun;5(3):161-9
pubmed: 23730331
Sci Rep. 2019 Aug 14;9(1):11804
pubmed: 31413311
CA Cancer J Clin. 2016 Nov 12;66(6):481-495
pubmed: 27314890
IARC Sci Publ. 1997;(138):65-176
pubmed: 9353664
Curr Oncol Rep. 2011 Feb;13(1):71-6
pubmed: 21080117
Skin Health Dis. 2022 Dec 11;3(2):e198
pubmed: 37013116
Rev Panam Salud Publica. 2017 Nov 30;41:e117
pubmed: 31384255
Transl Androl Urol. 2018 Oct;7(5):879-886
pubmed: 30456191
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4549-53
pubmed: 1316611
JAMA Netw Open. 2023 Dec 1;6(12):e2348002
pubmed: 38150257
Am J Surg Pathol. 2003 Nov;27(11):1448-53
pubmed: 14576478
Cureus. 2024 May 2;16(5):e59555
pubmed: 38832208
World J Urol. 2013 Aug;31(4):861-7
pubmed: 22116602
Urologia. 2019 Aug;86(3):105-114
pubmed: 31431169
Indian J Urol. 2022 Jul-Sep;38(3):210-215
pubmed: 35983107
BJU Int. 2024 Mar;133(3):314-323
pubmed: 37953505
Actas Dermosifiliogr. 2012 Jan;103(1):21-8
pubmed: 22445563
Urol Ann. 2023 Jul-Sep;15(3):278-284
pubmed: 37664092
Ann Oncol. 2006 Jan;17(1):5-19
pubmed: 16143594
Cell. 2010 Mar 19;140(6):883-99
pubmed: 20303878
J Clin Med. 2022 Dec 07;11(24):
pubmed: 36555871
Histopathology. 2023 Mar;82(4):508-520
pubmed: 36221864
Cureus. 2022 Aug 26;14(8):e28418
pubmed: 36176860
Cancer Causes Control. 2009 May;20(4):417-35
pubmed: 19002764
Int J Cancer. 2013 Sep 1;133(5):1173-9
pubmed: 23404289
Cancer Epidemiol Biomarkers Prev. 2018 Oct;27(10):1123-1132
pubmed: 29987099
Int J Cancer. 2020 Apr 1;146(7):1791-1799
pubmed: 31199509
Cancer Control. 2016 Oct;23(4):409-414
pubmed: 27842330
JMIR Public Health Surveill. 2022 Jul 6;8(7):e34874
pubmed: 35793140
Urol Ann. 2015 Jul-Sep;7(3):303-8
pubmed: 26229314